Ranjan Roy
Industry lead for retail at Writer and co-author of Margins, a newsletter covering the business of technology and technology of business. Previously held strategy roles at Adore Me and worked at the Financial Times and Bank of America.
Frontier AI’s Business Model Faces Pressure Ahead of IPOs
As Anthropic and OpenAI pursue ever-higher valuations and eventual public listings, Ranjan Roy argues that their frontier-AI business is showing strain in the metrics that matter most: spending by their biggest customers, token pricing, and demand for premium models. Alex Kantrowitz agrees those questions will require fuller financial disclosure, but argues that falling costs and fast-rising capability can still support growth—and that concerns about agentic systems should not be dismissed as corporate marketing. Their dispute over AI safety turns on the same question: whether the labs’ extraordinary-capability narrative reflects genuine risk, commercial incentive, or both.
AI Risk Claims Need Concrete Routes From Capability to Harm
Big Technology’s Alex Kantrowitz and Margins’ Ranjan Roy argue that Jacob Coxon’s viral warning about AI-driven human extinction has outpaced the technical case offered publicly. They do not dismiss longer-term danger, but say policy and corporate scrutiny should focus on concrete routes to harm—access controls, compute, credentials, data use, cybersecurity and shutdown mechanisms—rather than unsupported probability estimates. They also differ on whether the extinction narrative strengthens frontier labs commercially or creates regulatory and infrastructure risks for companies such as Anthropic.
Software’s Rebound Reflects a Longer Timeline for AI Disruption
Alex Kantrowitz and Ranjan Roy argue that AI’s advance is being priced and deployed faster than most organizations can absorb it. Salesforce’s rebound suggests investors had assumed an immediate collapse in software economics, while Meta’s AI workforce experiment showed that more automated activity can bring operational failures without proportionate customer benefit. The pair contend that the central question is not whether AI will disrupt software, but how long incumbents retain control of the workflows through which work gets done.
Big Tech’s $3 Trillion AI Commitments Sit Off Balance Sheet
Big Technology’s Alex Kantrowitz and Margins’ Ranjan Roy argue that Big Tech’s AI infrastructure wager is materially larger than reported capex, with leases, guarantees and externally financed data centers leaving much of the exposure outside conventional balance-sheet measures. Using Meta’s Hyperion project as an example, they examine how demand falling short of expectations could shift costs onto companies, lenders and institutional investors—even if AI itself proves useful. They also contrast Anthropic’s reported revenue acceleration with OpenAI’s slower growth and executive turnover, while treating travel as a practical test of AI’s ability to manage context and changing constraints.
AI Data-Center Debt Depends on Demand Beyond Two Frontier Labs
Alex Kantrowitz and Ranjan Roy argue that the AI boom’s financial risk lies in the gap between today’s debt-funded data-center buildout and the revenue needed to support it. Kantrowitz warns that a reversal in investor confidence could spread from AI stocks into capital spending and consumer demand, while Roy sees a more immediate problem of timing: frontier labs and hyperscalers may be growing quickly, but not quickly enough to meet the market’s near-term cash-flow expectations. Their dispute is over whether that adjustment would be a rational repricing or the start of a wider contraction.
Open-Weight Models Are Eroding Frontier Labs’ Pricing Power
Alex Kantrowitz and Ranjan Roy argue that Moonshot’s Kimi K3, by approaching frontier-model performance at a lower price and with planned open weights, weakens the case for paying a large premium to OpenAI or Anthropic. As capable models proliferate, they say, advantage will depend less on benchmark leadership than on products, infrastructure, trusted data practices and partnerships—areas where Google’s execution problems and OpenAI’s conflicts with allies expose different vulnerabilities.
Meta’s Low-Cost API Tests Frontier Models’ Pricing Power
Ranjan Roy and Alex Kantrowitz argue that AI products are converging on a common agentic workspace just as Meta moves to challenge the premium pricing of OpenAI and Anthropic. Roy says the durable advantage may lie in the organizational context, integrations, and domain expertise needed to make agents useful at scale; Kantrowitz counters that more capable models could eventually absorb much of that implementation work. Meta’s low-cost API strategy sharpens the question of whether frontier labs can retain pricing power when model capabilities and interfaces increasingly resemble one another.
Cheaper Models and Restricted Access Are Weakening the Frontier AI IPO Story
Alex Kantrowitz and Ranjan Roy argue that frontier AI is entering a more constrained and less certain commercial phase, as Anthropic’s Mythos release and OpenAI’s limited GPT-5.6 preview make access to top models partly dependent on government-approved customer lists. Their discussion centers on the risk that gating, cheaper adequate models, routing tools, distillation concerns and billing scrutiny could weaken the premium-usage story behind OpenAI and Anthropic’s valuations. They also treat Apple’s broad price increases as less a clean pass-through of memory costs than an exercise of market power.
Fable and Mythos Recall Targets the Wrong AI Cyber Risk
Alex Stamos, the former Facebook chief security officer and current Corridor chief product officer, argues that the U.S. government’s forced pullback of Anthropic’s Fable and Mythos models misidentified the real cybersecurity threshold in AI. In his account, the decisive shift came earlier with models such as Opus 4 and GPT-5, which made elite vulnerability discovery scalable, while Fable’s risks were not meaningfully distinct from capabilities already available in other U.S. and Chinese models. Stamos says policy should target exploit creation and offensive operations, not bug-finding itself, or risk weakening defenders and making U.S. AI less reliable.
AI Market Power Is Moving Beyond the Frontier Model
Alex Kantrowitz and Ranjan Roy argue that the AI market is shifting away from standalone model capability and toward control of infrastructure, access and workflow layers. Their discussion frames SpaceX’s IPO as a public-market AI-cloud story that complicates OpenAI’s ambitions, Anthropic’s Fable rollout as a case where safety policy also looks like market power, and OpenAI’s possible price cuts as a test of whether frontier models can remain premium products. Apple’s Siri, in their telling, matters for the same reason: usefulness may come less from the best model than from where the model sits.
Apple’s AI Advantage Is the Operating System, Not the Model
Alex Kantrowitz and Ranjan Roy argue that Apple’s reported WWDC AI plan is strategically plausible because it puts AI at the operating-system layer, where Apple still has unmatched distribution, but they remain skeptical that the company can execute after years of weak Siri and Apple Intelligence rollouts. The discussion extends that same question of control to Anthropic, whose safety warnings sit uneasily beside its push toward scale, and to Microsoft and OpenAI, whose partnership is turning into competition as each moves toward the other’s territory.
Only 18% of AI Coding Spend Is Shipping Into Products
Alex Kantrowitz and Ranjan Roy argue that the warning signs around the AI boom are less about a single spending scare than about a widening gap between AI usage and demonstrable value. Kantrowitz focuses on enterprise token spending that is not translating into shipped products, while Roy warns that “token maxing,” circular cloud financing and private-market valuation anchors are turning a promising technology into a reflexive capital cycle. Their discussion extends that concern from Anthropic’s surge past OpenAI to Robinhood’s AI trading plans and new data-for-services bargains, all pointing to the same test: whether AI adoption can become disciplined before the financial structure around it outruns the returns.
AI Companies Race Toward IPOs Before Growth Narratives Weaken
Alex Kantrowitz and Ranjan Roy argue on Big Technology that OpenAI’s potential IPO is less a sign of financial readiness than a race to define the AI market before Anthropic does. They say OpenAI’s huge revenue and deep losses, Anthropic’s reported acceleration and possible profitability, and SpaceX’s AI-heavy IPO pitch all point to companies trying to sell public investors on future infrastructure demand before the current growth story weakens. The discussion also frames rising public hostility to AI as a practical risk: the industry needs capital to build, but it may also need permission.
Microsoft’s OpenAI Advantage Has Not Become an AI Product Lead
Alex Kantrowitz and Ranjan Roy use Satya Nadella’s 2022 email about Microsoft’s dependence on OpenAI and Nvidia to argue that the company saw the central AI risk early but did not turn privileged model access into a decisive product advantage. Their broader case is that distribution and partnerships are proving inadequate without control, AI-native execution, and usable integrations — a problem they see not only at Microsoft, but also in Apple’s weak ChatGPT-Siri integration and Google’s uneven AI products.
Real AI Gains Are Powering Unproven Compute, IPO, and Layoff Narratives
Alex Kantrowitz and Ranjan Roy read Anthropic’s SpaceX compute deal as both a real answer to Claude’s capacity constraints and a piece of market theater around AI demand, financing and IPO timing. Kantrowitz argues the Colossus 1 capacity could materially ease Anthropic’s limits and sharpen its race with OpenAI; Roy cautions that explosive usage and infrastructure announcements are also serving valuation narratives. The discussion extends that frame to OpenAI trial messages, Anthropic’s Mythos security claims and AI-linked layoffs: genuine progress, they argue, is being folded into stories that remain only partly proven.